Category: Prostate Cancer

Not all prostate biopsies are the same. Traditional methods can require more needles and carry higher risks. In-bore MRI guidance offers a safer, more precise alternative—helping doctors target aggressive cancers with confidence while reducing unnecessary complications. keep reading

What does your expected lifespan have to do with prostate cancer care? More than you might think. Explore why doctors weigh age, health, and lifestyle when recommending or discouraging certain treatments. keep reading

Prostate cancer is the most common nonskin cancer in men, yet many don’t know the key facts that shape detection and treatment. From risks to survival rates, here are 10 essential insights every patient should understand. keep reading

Not all biopsies are created equal. When it comes to planning radiation treatment, real-time MRI guidance makes all the difference. Learn how this advanced approach helps doctors target cancer more precisely and reduce the risk of prostate cancer returning. keep reading

Could a simple urine test change how prostate cancer is diagnosed? Research on urine spermine suggests it may help identify men at higher risk while sparing others from unnecessary biopsies. Combined with MRI, it offers a safer path to early detection. keep reading

“I wish I hadn’t chosen that treatment.” For many men with localized prostate cancer, decision regret is a painful reality. Studies show that clear communication, decision aids, and shared decision-making can help patients feel more confident and supported in their choices. keep reading

Is great care only about medical results? A large study suggests not. Patients consistently rated doctors higher when they felt listened to, understood, and respected, while poor communication and long wait times fueled dissatisfaction. keep reading

The “Prostate 8” program highlights eight lifestyle habits—from eating cruciferous vegetables and cooked tomatoes to avoiding whole milk—that research suggests may help men with prostate cancer improve outcomes. Together, these choices may reduce risks and restore a sense of control. keep reading

Should every man on active surveillance be monitored the same way? New evidence suggests genetics may hold the answer. Polygenic risk scores could one day refine prostate cancer protocols, helping patients get care that matches their unique risk. keep reading

A European study of nearly 600 men found that negative prostate MRI results accurately predicted no cancer in 96% of cases. Over three years, most men safely avoided biopsy while being monitored, suggesting pre-biopsy MRI can reduce unnecessary procedures without added risk. keep reading